文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

化疗相关肝损伤对结直肠癌肝转移行部分肝切除术后结局影响的系统评价

Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
PubMed 文献 · Br J Surg · 2017-05-25

该研究通过国际多中心788例因结直肠癌肝转移行肝切除术患者的合并数据库,分析化疗相关肝损伤(CALI)对术后结局的影响。多因素分析显示,严重窦状隙扩张与术后严重并发症增加相关,脂肪性肝炎与肝脏手术特异性并发症增加相关,而严重脂肪变则与这些并发症减少相关。奥沙利铂治疗与严重窦状隙扩张相关。

要点

  • 严重窦状隙扩张增加部分肝切除术后严重并发症风险。
  • 脂肪性肝炎增加肝脏手术特异性并发症风险。
  • 奥沙利铂治疗与严重窦状隙扩张相关。

核心结论

  • 严重窦状隙扩张和脂肪性肝炎与部分肝切除术后严重并发症及肝脏手术特异性并发症增加相关。
  • 严重窦状隙扩张患者术后肝衰竭发生更频繁。

研究设计与样本

  • 系统评价与多中心合并数据库分析,检索PubMed和Embase 2004年1月1日至2013年12月31日文献。
  • 合并数据库包含8个中心788例因结直肠癌肝转移行肝切除术的患者。
  • 采用单因素和多因素二元逻辑回归模型,结果以比值比(OR)及95%置信区间表示。

临床怎么用

  • 对于接受奥沙利铂化疗的结直肠癌肝转移患者,术前应评估肝损伤情况以识别严重窦状隙扩张高风险者。
  • 术后应关注严重窦状隙扩张和脂肪性肝炎患者的并发症风险,加强围术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of chemotherapy-associated liver injury (CALI) on postoperative outcome in patients undergoing partial hepatectomy for colorectal liver metastases (CRLM) remains controversial. The objective of this study was to clarify the effect of CALI (sinusoidal dilatation (SD), steatosis and steatohepatitis) on postoperative morbidity and mortality by investigating a large data set from multiple international centres. METHODS: PubMed and Embase were searched for studies published between 1 January 2004 and 31 December 2013 with keywords 'chemotherapy', 'liver resection', 'outcome' and 'colorectal metastases' to identify potential collaborating centres. Univariable and multivariable analyses were performed using binary logistic regression models, with results presented as odds ratios (ORs) with 95 per cent confidence intervals. RESULTS: A consolidated database comprising 788 patients who underwent hepatectomy for CRLM in eight centres was obtained. In multivariable analyses, severe SD was associated with increased major morbidity (Dindo-Clavien grade III-V; OR 1·73, 95 per cent c.i. 1·02 to 2·95; P = 0·043). Severe steatosis was associated with decreased liver surgery-specific complications (OR 0·52, 95 per cent c.i. 0·27 to 1·00; P = 0·049), whereas steatohepatitis was linked to an increase in these complications (OR 2·08, 1·18 to 3·66; P = 0·012). Subgroup analysis showed that lobular inflammation was the sole component associated with increased overall morbidity (OR 2·22, 1·48 to 3·34; P = 0·001) and liver surgery-specific complications (OR 3·35, 2·11 to 5·32; P < 0·001). Finally, oxaliplatin treatment was linked to severe SD (OR 2·74, 1·67 to 4·49; P < 0·001). CONCLUSION: An increase in postoperative major morbidity and liver surgery-specific complications was observed after partial hepatectomy in patients with severe SD and steatohepatitis. Postoperative liver failure occurred more often in patients with severe SD.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Zhao J, van Mierlo KMC, Gómez-Ramírez J, et al. Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases. Br J Surg. 2017. PMID: 28542731. doi:10.1002/bjs.10572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。